Sugammadex effectively reverses neuromuscular blockade in myasthenia gravis patients, ensuring rapid recovery and minimal complications. The review of 24 studies with 1679 patients showed no ...
LAKE ZURICH, Ill., December 18, 2025--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Fresenius Kabi, a provider of injectable medications, has announced the U.S. launch of its Rocuronium Bromide Injection, a product offered with RFID-enabled labels. Rocuronium Bromide Injection is ...
Baudax Bio, Inc. BXRX announced additional positive data from its phase II study of BX1000, which is used as a neuromuscular blockade (“NMB”) in patients undergoing elective surgery. The efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results